SEC Form 4 · accession 0000785161-26-000191
Encompass Health Corp · EHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark J Tarr
Officer — President & CEO · Director
Period of report
Aug 10, 2026
Accepted (ET)
Aug 11, 2026 · 2:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000785161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common StockF1 | Aug 10, 2026 | S | 171,569 | $125.46 | D | 269,393 | D | |
| Encompass Health Common StockF2 | Aug 10, 2026 | S | 1,579 | $126.06 | D | 267,814 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
- F2This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.